On Friday, November 1, 2019, the White House announced the nomination of Dr. Stephen Hahn, MD, as the next US Food and Drug Administration (FDA) commissioner. In response, the National Organization for Rare Disorders (NORD) offers support to the appointment of Dr. Hahn as the next FDA commissioner.
Dr. Hahn will bring to FDA strong research and management credentials as well as a commitment to improving health care for patients. We, as an organization, urge the Senate to move quickly to confirm his appointment.
Dr. Stephen Hahn is currently a practicing radiation oncologist from the University of Texas MD Anderson Cancer Center. Read his complete biography.
